Dambinova Svetlana: Brain Biomarkers for Stroke Assessment. Clinical studies of NR2 biomarkers to assess ischemic stroke

Dambinova Svetlana: 1. Brain Biomarkers for Stroke Assessment. 1.3. Clinical studies of NR2 biomarkers to assess ischemic stroke The lecture presents current state of discovery of biomarkers for stroke diagnostics. Sources of candidate biological markers and their role in brain functioning are considered. The neurotoxicity as an early stage of cerebral ischemia and NMDA glutamate receptors as key neurovascular biomarkers are discussed. Peer-reviewed publications are presenting clinical studies results of NR2 peptide and antibody blood assays combined with neuroimaging. The potential of neurotoxicity biomarkers for early diagnosis of hyper-acute and acute ischemic strokes at Emergency Dept, surgery, and hospital admission is demonstrated #Dambinova #Дамбинова #Brain #Biomarkers #Assessment #Brain #Damage